News

Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what ...
The U.S. Federal Trade Commission is probing complaints about telehealth platform Hims & Hers regarding its advertising and ...
Hims & Hers shares fall after a report says the FTC has investigated its cancellation policies and billing practices for over ...
Hims & Hers Health (NYSE:HIMS) stock fell 4.1% in after-hours trading on Thursday following a Bloomberg report that revealed ...
Telehealth and wellness platform Hims & Hers Health ($HIMS) recently disappointed investors with its mixed second-quarter ...
Investing.com -- Hims & Hers Health (NYSE:HIMS) stock dropped 2.6% on Friday following reports that the Federal Trade Commission has been investigating the telehealth company's business practices for ...
Hims & Hers Health (NYSE:HIMS) stock fell 5% in after-hours trading on Thursday following a Bloomberg report that revealed ...
After Bloomberg reported, citing people familiar with the probe, that the Federal Trade Commission has been investigating ...
Berkshire Hathaway invests in UnitedHealth; FTC investigates Hims & Hers for advertising practices; U.S. health department ...
The US health sector is bustling with activity. Key developments include an FTC investigation into Hims & Hers' practices, ...
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than ...
For more than a year, the Federal Trade Commission has been investigating Hims & Hers Health Inc.’s business practices, including whether it has made it too hard for customers to cancel subscriptions, ...